Plant-Based Cancer Drugs

Prof. Jamal Mahajna

Principal Researcher

Latest Publications

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells.

Koren Carmi, Y., Agbarya, A., Khamaisi, H., Farah, R., Shechtman, Y., Korobochka, R., Gopas, J., Mahajna, J.
Translational Oncol. 10.1016/j.tranon.2024.101939
2024

Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer

Wang, J., Beghelli, D., Amici, A., Sut, S., Dall’Acqua, S., Lupidi, G., Dal Ben, D., Bistoni, O., Tomassoni, D., Belletti, B., Musa, S., Mahajna, J., Pucciarelli, S., & Marchini, C.
Biomolecules, 14(11), 1454
2024

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells

Yifat Koren Carmi, Abed Agbarya, Hazem Khamaisi, Raymond Farah, Yelena Shechtman, Roman Korobochka, Jacob Gopas, Jamal Mahajna
2024

Secreted soluble factors from tumor-activated mesenchymal stromal cells confer platinum chemoresistance to OC cells and JAK and c-MET kinase inhibitors restore platinum sensitivity to ovarian cancer cells

Yifat Koren Carmi, Hazem Khamaisi, Jacob Gopas and Jamal Mahajna
Int. J. Mol. Sci. 2023, 24(9), 7730; 
2023